Vaporized Cannabis for Acute Migraine Yields Rapid Relief Vaporized Cannabis for Acute Migraine Yields Rapid Relief
In the first randomized controlled trial, vaporized cannabis containing a THC-CBD mix led to rapid and sustained relief of acute migraine.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - April 17, 2024 Category: Internal Medicine Tags: Neurology & Neurosurgery News Source Type: news
Use of CT Angiogram on the Rise for Headache, Dizziness in Emergency Department
WEDNESDAY, April 17, 2024 -- There was a 67.4 percent increase in head and neck computed tomography angiography (CTA) ordering for emergency department patients presenting for headache or dizziness from 2017 through 2021, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 17, 2024 Category: Pharmaceuticals Source Type: news
Tension, Other Headache Types Robustly Linked to Suicide Tension, Other Headache Types Robustly Linked to Suicide
Headache, including tension-type, migraine, and posttraumatic, are robustly associated with both attempted and completed suicide, a large study shows.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - April 16, 2024 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
No New Safety Signals Seen With Migraine Prevention Drug
(MedPage Today) -- DENVER -- No new safety signals emerged with daily atogepant (Qulipta) for migraine prevention, an interim analysis of a long-term safety extension study showed, and improvements in efficacy were sustained.
After an average... (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - April 16, 2024 Category: Neurology Source Type: news
IV Ketamine Promising for Refractory Headache in Kids IV Ketamine Promising for Refractory Headache in Kids
Infusions of ketamine are an effective, safe, and well tolerated option for severe, refractory headache in children, researchers report.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - April 16, 2024 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
First Long-Term Data on Atogepant for Migraine Prevention First Long-Term Data on Atogepant for Migraine Prevention
Interim data from an ongoing open-label extension study support the long-term safety and efficacy of atogepant for prevention of chronic and episodic migraine.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - April 16, 2024 Category: Internal Medicine Tags: Neurology & Neurosurgery News Source Type: news
One in 3 Women With Migraines Say Attacks Occur During Periods
MONDAY, April 15, 2024 -- Among U.S. women with migraine, a third say the attacks tend to coincide with their periods, a new survey finds.
Migraines that occur during menstruation are often frequent and severe, but only about one in five... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 15, 2024 Category: General Medicine Source Type: news
Must-know guide to treating - and preventing - a migraine
NHS GP Hana Patel, based in London said there's some simple steps you can take - in combination with medicine - to prevent the agony of a migraine. (Source: the Mail online | Health)
Source: the Mail online | Health - April 11, 2024 Category: Consumer Health News Source Type: news
NICE recommends first oral treatment for migraine prevention
New guidance from NICE will give 170,000 people in England more treatment options for preventing migraine attacks. The final draft guidance recommends that patients with both chronic and episodic migraines should be offered treatment with atogepant, the first oral preventative treatment option available for patients who suffer from migraines. The medication, made by AbbVie, is... Read moreThe post NICE recommends first oral treatment for migraine prevention appeared first on Nursing in Practice. (Source: Nursing in Practice)
Source: Nursing in Practice - April 11, 2024 Category: Nursing Authors: Carolyn Scott Tags: Men's health Women's health headache migraine pain Source Type: news
Huge breakthrough as new NHS migraine pill could help 170,000
It is thought around 10 million Brits suffer from the debilitating condition - with up to 170,000 expected to benefit from this new drug. (Source: Daily Express - Health)
Source: Daily Express - Health - April 11, 2024 Category: Consumer Health News Source Type: news
New migraine pill could help 170,000 in England
The oral treatment - the first of its kind - could soon be available after being recommended for NHS use. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - April 10, 2024 Category: Consumer Health News Source Type: news
First migraine pill could help 170,000 in England
The oral treatment - the first of its kind - could soon be available after being recommended for NHS use. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - April 10, 2024 Category: Consumer Health News Source Type: news
'Life-changing' once-a-day migraine pill which halves the number of crippling attacks gets green light for NHS use
The pill - sold under the brand name Aquipta and made by pharmaceutical company AbbVie - could be a blessing for some 170,000 sufferers in England. (Source: the Mail online | Health)
Source: the Mail online | Health - April 10, 2024 Category: Consumer Health News Source Type: news
NICE backs first oral treatment to prevent chronic and episodic migraines
Draft guidance from NICE backs the first oral treatment for prevention of chronic and episodic migraines in a move that could benefit around 170,000 people in England. (Source: GP Online News)
Source: GP Online News - April 10, 2024 Category: Primary Care Tags: Clinical News Source Type: news
LONG COVID leaves healthy boy, 12, in a wheelchair - as well as crippling pain, fatigue and a FOUR-YEAR migraine
A seventh grader from Atlanta [left] has detailed his struggle with long Covid, including fatigue and migraines that have affected his ability to go to school and play with friends. (Source: the Mail online | Health)
Source: the Mail online | Health - April 10, 2024 Category: Consumer Health News Source Type: news
